These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24788149)
1. Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells. Wang JW; Wan XY; Zhu HT; Lu C; Yu WL; Yu CH; Shen Z; Li YM PLoS One; 2014; 9(4):e96124. PubMed ID: 24788149 [TBL] [Abstract][Full Text] [Related]
2. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ. Yang M; Chen Z; Xiang S; Xia F; Tang W; Yao X; Zhou B BMC Complement Med Ther; 2020 Dec; 20(1):377. PubMed ID: 33308192 [TBL] [Abstract][Full Text] [Related]
3. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195 [TBL] [Abstract][Full Text] [Related]
4. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy. Zhou SW; Zhang M; Zhu M Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688 [TBL] [Abstract][Full Text] [Related]
5. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360 [TBL] [Abstract][Full Text] [Related]
6. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway. Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045 [TBL] [Abstract][Full Text] [Related]
7. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863 [TBL] [Abstract][Full Text] [Related]
8. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Li M; Xu C; Shi J; Ding J; Wan X; Chen D; Gao J; Li C; Zhang J; Lin Y; Tu Z; Kong X; Li Y; Yu C Gut; 2018 Dec; 67(12):2169-2180. PubMed ID: 28877979 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cells. Chen X; Liu H; Chen K; Guo Y; Mo T; Gao T J Biosci; 2022; 47():. PubMed ID: 36210729 [TBL] [Abstract][Full Text] [Related]
10. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model. Im AR; Kim YH; Lee HW; Song KH J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979 [TBL] [Abstract][Full Text] [Related]
11. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Lee MR; Yang HJ; Park KI; Ma JY Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol Attenuates High-Fat Diet-Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression. Yuan W; Zhang M; Wang C; Li B; Li L; Ye F; Xu C J Pharmacol Exp Ther; 2022 May; 381(2):96-105. PubMed ID: 35221291 [TBL] [Abstract][Full Text] [Related]
14. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism. He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994 [TBL] [Abstract][Full Text] [Related]
15. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. Zheng L; Lv GC; Sheng J; Yang YD J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876 [TBL] [Abstract][Full Text] [Related]
16. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
17. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways. Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. Chu JH; Wang H; Ye Y; Chan PK; Pan SY; Fong WF; Yu ZL World J Gastroenterol; 2011 May; 17(19):2379-88. PubMed ID: 21633637 [TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice. Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139 [TBL] [Abstract][Full Text] [Related]
20. Caveolin1 protects against diet induced hepatic lipid accumulation in mice. Li M; Chen D; Huang H; Wang J; Wan X; Xu C; Li C; Ma H; Yu C; Li Y PLoS One; 2017; 12(6):e0178748. PubMed ID: 28570612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]